State of Wisconsin Investment Board’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
84,726
+49,871
| +143% | +$1.01M | ﹤0.01% | 1363 |
|
|
2025
Q1 | $633K | Sell |
34,855
-5,458
| -14% | -$99.1K | ﹤0.01% | 1655 |
|
|
2024
Q4 | $1.02M | Sell |
40,313
-1,047
| -3% | -$26.5K | ﹤0.01% | 1516 |
|
|
2024
Q3 | $1.41M | Buy |
41,360
+4,590
| +12% | +$156K | ﹤0.01% | 1445 |
|
|
2024
Q2 | $1.36M | Buy |
36,770
+538
| +1% | +$19.9K | ﹤0.01% | 1444 |
|
|
2024
Q1 | $1.52M | Sell |
36,232
-4,286
| -11% | -$180K | ﹤0.01% | 1314 |
|
|
2023
Q4 | $1.61M | Buy |
40,518
+8,569
| +27% | +$340K | ﹤0.01% | 1278 |
|
|
2023
Q3 | $879K | Sell |
31,949
-1,238
| -4% | -$34.1K | ﹤0.01% | 1442 |
|
|
2023
Q2 | $1.13M | Sell |
33,187
-4,678
| -12% | -$159K | ﹤0.01% | 1424 |
|
|
2023
Q1 | $1.36M | Buy |
37,865
+299
| +0.8% | +$10.8K | ﹤0.01% | 1393 |
|
|
2022
Q4 | $1.67M | Sell |
37,566
-414
| -1% | -$18.5K | 0.01% | 1362 |
|
|
2022
Q3 | $1.07M | Sell |
37,980
-2,319
| -6% | -$65.2K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $1.09M | Sell |
40,299
-21,301
| -35% | -$574K | ﹤0.01% | 1598 |
|
|
2022
Q1 | $2.1M | Buy |
61,600
+10,900
| +21% | +$371K | ﹤0.01% | 1479 |
|
|
2021
Q4 | $1.96M | Hold |
50,700
| – | – | ﹤0.01% | 1281 |
|
|
2021
Q3 | $2.74M | Buy |
50,700
+1,000
| +2% | +$54K | 0.01% | 1208 |
|
|
2021
Q2 | $1.66M | Buy |
+49,700
| New | +$1.66M | ﹤0.01% | 1327 |
|
|
2018
Q3 | – | Sell |
-28,814
| Closed | -$218K | – | 1545 |
|
|
2018
Q2 | $218K | Sell |
28,814
-20,120
| -41% | -$152K | ﹤0.01% | 1420 |
|
|
2018
Q1 | $1.71M | Sell |
48,934
-6,733
| -12% | -$235K | ﹤0.01% | 994 |
|
|
2017
Q4 | $2.37M | Hold |
55,667
| – | – | 0.01% | 955 |
|
|
2017
Q3 | $2.39M | Hold |
55,667
| – | – | 0.01% | 950 |
|
|
2017
Q2 | $2.06M | Buy |
55,667
+5,667
| +11% | +$210K | 0.01% | 944 |
|
|
2017
Q1 | $2.71M | Buy |
50,000
+33,676
| +206% | +$1.82M | 0.01% | 886 |
|
|
2016
Q4 | $867K | Buy |
+16,324
| New | +$867K | ﹤0.01% | 1212 |
|